TGIF Patient Worthians!
This week we have promising results on promising results. First up is news on a Dravet syndrome treatment. Second is a Lupus Nephritis drug in the works!
Third is positive news for the multiple myeloma community. And lastly, ulcerative colitis patients may want to rejoice due to the results of a most recent clinical trial!
So sit back and relax, and check out this week’s Editor’s Choice.
[one_half]
CBD Shows Promising Results in Treating Dravet Syndrome
At this point, we’ve all probably seen videos of the good marijuana can do for epilepsy seizures.
What about cannabidiol, a topically applied oil? Read more about it’s effects on a severe form of epilepsy here.
[/one_half_last] [one_half]
This New Drug Would Change Lupus Nephritis Treatment Forever
Aurinia Pharmaceuticals is in phase 3 trials for a drug that has the potential to achieve remission for lupus nephritis patients!
Read more here.
[/one_half_last] [one_half]
New Advancements in Stem Cell Transplantation!
BioLineRx Ltd. is initiation a Phase 3 trial for it’s new treatment for multiple myeloma.
Get the basics here.
[/one_half_last] [one_half]
This Just In! Promising Results from Ulcerative Colitis Clinical Trial!
While making a rare disease go away is ideal, maintaining health with a rare condition is also a plus.
Check out this ulcerative colitis maintenance treatment news here.
[/one_half_last] [one_half]
